Addition — 2019 Investments

2 investments dated 2019 · listed companies and verified rows first · show all

Rev Genomicsrevgenomics.com inSeries A · Apr 2019

Rev Genomics uses genomic selection, tissue culture, and molecular analysis to develop high-value crop cultivars for breeders and seed banks.

AgTechBiotechHealthtechMedical DevicesSan Francisco, US

Bertrand Vick(CEO)inRobert John Markelz(Executive Officer, Director, Promoter)Gloria E Webster(Director, Promoter)Robert Markelz(Vice President of Genomics)

Co-investorsY Combinator Merida Capital Holdings Agrolimen Ventures Floret Ventures Gron Ventures, Llc L4 Inc.+3 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Operiant

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.